老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
20/20 BIOLABS INC
0.4808
+0.0050
1.05%
成交量：
3.42萬
成交額：
1.64萬
市值：
614.00萬
市盈率：
-0.48
高：
0.5000
開：
0.4785
低：
0.4601
收：
0.4758
52周最高：
50.00
52周最低：
0.4011
股本：
1,277.03萬
流通股本：
1,084.73萬
量比：
0.86
換手率：
0.31%
股息：
- -
股息率：
- -
每股收益(TTM):
-0.9997
每股收益(LYR):
-0.7600
淨資產收益率：
-331.22%
總資產收益率：
-62.37%
市淨率：
3.79
市盈率(LYR):
-0.63
資料載入中...
總覽
公司
新聞資訊
公告
20/20 Biolabs 發布2026年第二季度財報，癌症檢測營收創季度新高
美股速递
·
08/17
20/20 BIOLABS INC 亮相台灣生物科技展，並赴台北、東京、首爾會見戰略伙伴，推進東亞整合戰略
美股速递
·
07/28
20/20 Biolabs與Streeterville Capital就E系列優先股達成暫停協議
美股速递
·
07/23
熱門話題-20/20 Biolabs 因埃博拉和漢坦病毒檢測計劃股價跳漲
路透中文
·
05/22
20/20 Biolabs股價盤前飆升19.5%至1.44美元，公司宣佈埃博拉與漢坦病毒檢測準備計劃
美股速递
·
05/22
20/20 BIOLABS INC啓動緊急預案 應對埃博拉及漢坦病毒檢測潛在需求激增
美股速递
·
05/22
20/20 Biolabs Inc：協議達成，Rokit同意承擔雙方認可銷售與市場開支的三分之一
美股速递
·
03/24
20/20 Biolabs與美國Rokit Healthcare達成獨家授權協議，將先進慢性腎病預測技術整合入其長壽檢測項目
美股速递
·
03/24
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/AIDX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"AIDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIDX\",,,,,undefined,":{"symbol":"AIDX","market":"US","secType":"STK","nameCN":"20/20 BIOLABS INC","latestPrice":0.4808,"timestamp":1789588111953,"preClose":0.4758,"halted":0,"volume":34155,"delay":0,"changeRate":0.010508617065994125,"floatShares":10847300,"shares":12770300,"eps":-0.999676,"marketStatus":"交易中","change":0.005,"latestTime":"09-16 15:59:54 EDT","open":0.4785,"high":0.5,"low":0.4601,"amount":16361.2170513,"amplitude":0.083859,"askPrice":0.5,"askSize":120,"bidPrice":0.4811,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.999676,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4758,"preHourTrading":{"tag":"盘前","latestPrice":0.48,"preClose":0.4758,"latestTime":"09:29 EDT","volume":3320,"amount":1548.0635439999999,"timestamp":1789565396196,"change":0.0042,"changeRate":0.008827,"amplitude":0.064313},"volumeRatio":0.862382},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIDX\",,,,,undefined,":{"symbol":"AIDX","floatShares":10847300,"roa":"-62.37%","roe":"-331.22%","lyrEps":-0.759999,"volumeRatio":0.862382,"shares":12770300,"dividePrice":0,"high":0.5,"amplitude":0.083859,"preClose":0.4758,"low":0.4601,"week52Low":0.4011,"pbRate":"3.79","psRate":"3.01","week52High":50,"institutionHeld":0,"latestPrice":0.4808,"committee":-0.090909,"eps":-0.999676,"divideRate":0,"volume":34155,"delay":0,"ttmEps":-0.999676,"open":0.4785,"prevYearClose":50,"prevWeekClose":0.56,"prevMonthClose":0.6162,"prevQuarterClose":0.5497,"fiveDayClose":0.5646,"twentyDayClose":0.5161,"sixtyDayClose":0.6118},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AIDX\",params:#limit:5,,,undefined,":[{"date":"2026-09-02","symbol":"AIDX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788379200000,"name":null,"time":"盤後","dateTimestamp":1788321600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AIDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AIDX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AIDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AIDX","date":"2026-09-15","current":-0.480056,"percent":0.816901,"low":-75.813841,"twenty":-5.553938,"median":-1.957816,"eighty":-1.159725,"high":-0.82661,"avg":-4.65894,"sd":8.227639,"marketCap":6646942},"quantilePoints":[{"date":"2026-02-20","current":-75.813841,"twenty":-64.065097,"median":-46.44198,"eighty":-28.818864,"marketCap":246781483},{"date":"2026-02-27","current":-12.969412,"twenty":-44.148132,"median":-25.366644,"eighty":-17.267187,"marketCap":42216706},{"date":"2026-03-06","current":-9.85421,"twenty":-31.342746,"median":-15.019766,"eighty":-10.648904,"marketCap":32076419},{"date":"2026-03-13","current":-7.883368,"twenty":-23.904406,"median":-10.776055,"eighty":-8.926007,"marketCap":25661135},{"date":"2026-03-20","current":-5.976101,"twenty":-17.858388,"median":-9.615801,"eighty":-7.966017,"marketCap":19452796},{"date":"2026-03-27","current":-5.499285,"twenty":-16.249978,"median":-8.900577,"eighty":-6.346175,"marketCap":17900711},{"date":"2026-04-02","current":-5.976101,"twenty":-12.969412,"median":-8.614487,"eighty":-5.976101,"marketCap":19452796},{"date":"2026-04-10","current":-5.139333,"twenty":-12.14293,"median":-7.915156,"eighty":-5.590374,"marketCap":19215046},{"date":"2026-04-17","current":-4.804159,"twenty":-10.776055,"median":-6.427806,"eighty":-5.251057,"marketCap":17961891},{"date":"2026-04-24","current":-4.524848,"twenty":-10.617116,"median":-6.13504,"eighty":-5.139333,"marketCap":16917595},{"date":"2026-05-01","current":-4.441054,"twenty":-9.85421,"median":-5.976101,"eighty":-4.846056,"marketCap":16604306},{"date":"2026-05-08","current":-3.8545,"twenty":-9.377393,"median":-5.624299,"eighty":-4.776228,"marketCap":14411284},{"date":"2026-05-15","current":-3.855058,"twenty":-9.027728,"median":-5.348817,"eighty":-4.329329,"marketCap":14413373},{"date":"2026-05-22","current":-2.443886,"twenty":-8.900577,"median":-5.232126,"eighty":-4.245536,"marketCap":12583766},{"date":"2026-05-29","current":-1.957816,"twenty":-8.900577,"median":-5.158442,"eighty":-3.904776,"marketCap":10080951},{"date":"2026-06-05","current":-1.791711,"twenty":-8.671705,"median":-5.064547,"eighty":-3.826569,"marketCap":9225662},{"date":"2026-06-12","current":-1.772339,"twenty":-8.156743,"median":-4.908901,"eighty":-3.670154,"marketCap":9125914},{"date":"2026-06-18","current":-1.329048,"twenty":-7.985089,"median":-4.804159,"eighty":-2.114441,"marketCap":6843374},{"date":"2026-06-26","current":-1.216525,"twenty":-7.908798,"median":-4.776228,"eighty":-1.973458,"marketCap":6263984},{"date":"2026-07-02","current":-1.256094,"twenty":-7.476484,"median":-4.524848,"eighty":-1.791753,"marketCap":6467726},{"date":"2026-07-10","current":-1.201481,"twenty":-6.690818,"median":-4.32919,"eighty":-1.733182,"marketCap":6186520},{"date":"2026-07-17","current":-1.091843,"twenty":-6.38699,"median":-4.273467,"eighty":-1.338858,"marketCap":5621987},{"date":"2026-07-24","current":-1.05516,"twenty":-6.313052,"median":-4.115237,"eighty":-1.263471,"marketCap":5433102},{"date":"2026-07-31","current":-0.82661,"twenty":-6.230403,"median":-3.896396,"eighty":-1.231405,"marketCap":4256283},{"date":"2026-08-07","current":-0.931302,"twenty":-5.976101,"median":-3.8545,"eighty":-1.207466,"marketCap":4795349},{"date":"2026-08-14","current":-1.233904,"twenty":-5.976101,"median":-3.784811,"eighty":-1.186107,"marketCap":6353471},{"date":"2026-08-21","current":-1.083215,"twenty":-5.925241,"median":-3.686913,"eighty":-1.157297,"marketCap":6298340},{"date":"2026-08-28","current":-1.36104,"twenty":-5.709084,"median":-2.283285,"eighty":-1.157297,"marketCap":7913756},{"date":"2026-09-04","current":-1.343031,"twenty":-5.644654,"median":-2.019642,"eighty":-1.159606,"marketCap":7809040},{"date":"2026-09-11","current":-1.186875,"twenty":-5.590374,"median":-1.983886,"eighty":-1.16008,"marketCap":6901071},{"date":"2026-09-15","current":-1.143169,"twenty":-5.553938,"median":-1.957816,"eighty":-1.159725,"marketCap":6646942}],"updateTime":1789568958566},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AIDX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1143876177","title":"20/20 Biolabs 發布2026年第二季度財報，癌症檢測營收創季度新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1143876177","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143876177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:32","pubTimestamp":1786969941,"startTime":"0","endTime":"0","summary":"20/20 Biolabs 今日公布了2026年第二季度财务业绩及近期运营进展。报告显示，公司癌症检测业务收入达到创纪录的季度水平，成为本季度最大亮点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157820449","title":"20/20 BIOLABS INC 亮相台灣生物科技展，並赴台北、東京、首爾會見戰略伙伴，推進東亞整合戰略","url":"https://stock-news.laohu8.com/highlight/detail?id=1157820449","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157820449?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 04:35","pubTimestamp":1785184545,"startTime":"0","endTime":"0","summary":"20/20 BIOLABS INC（美国上市公司，股票代码：AIDX）近日积极参与了在台湾举办的生物科技盛会——Bio Asia-Taiwan（亚洲生技大会）。不仅如此，公司代表团还马不停蹄地奔赴台北、东京与首尔三地，与多家战略合作方进行了深入会晤，旨在进一步加速其东西亚区域整合战略的落地实施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332308","title":"20/20 Biolabs與Streeterville Capital就E系列優先股達成暫停協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332308","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103332308?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 20:32","pubTimestamp":1784809932,"startTime":"0","endTime":"0","summary":"20/20 Biolabs公司宣布，已与Streeterville Capital就其E系列可转换优先股达成一项暂停协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312521","title":"熱門話題-20/20 Biolabs 因埃博拉和漢坦病毒檢測計劃股價跳漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312521","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637312521?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 21:12","pubTimestamp":1779455530,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nL4T41Z12X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STAB","BK4139","BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179332966","title":"20/20 Biolabs股價盤前飆升19.5%至1.44美元，公司宣佈埃博拉與漢坦病毒檢測準備計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1179332966","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179332966?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 21:03","pubTimestamp":1779454999,"startTime":"0","endTime":"0","summary":"20/20 Biolabs的股价在盘前交易中大幅上涨19.5%，报收于1.44美元。这一显著的市场反应，紧随公司宣布其针对埃博拉病毒与汉坦病毒的检测准备计划之后。该计划表明公司正积极拓展其在传染病诊断领域的布局，市场对此给予了积极解读。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129935856","title":"20/20 BIOLABS INC啓動緊急預案 應對埃博拉及漢坦病毒檢測潛在需求激增","url":"https://stock-news.laohu8.com/highlight/detail?id=1129935856","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129935856?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 20:33","pubTimestamp":1779453235,"startTime":"0","endTime":"0","summary":"20/20 BIOLABS INC已启动紧急规划，旨在为埃博拉病毒与汉坦病毒的实验室检测能力做好预案，以应对一旦相关疫情暴发可能导致的检测需求激增。\n该公司正积极筹备，确保其检测服务在潜在公共卫生危机中能够迅速响应，满足可能出现的超额需求。此举凸显了生物科技公司在突发传染病防控体系中的关键作用与前瞻性布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127936300","title":"20/20 Biolabs Inc：協議達成，Rokit同意承擔雙方認可銷售與市場開支的三分之一","url":"https://stock-news.laohu8.com/highlight/detail?id=1127936300","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127936300?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 20:33","pubTimestamp":1774355620,"startTime":"0","endTime":"0","summary":"根据最新协议，Rokit公司已承诺向20/20 Biolabs Inc报销经双方共同确认的销售与市场相关费用的三分之一。这一安排明确了双方在推广活动中的财务分担比例，为未来的合作奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156640095","title":"20/20 Biolabs與美國Rokit Healthcare達成獨家授權協議，將先進慢性腎病預測技術整合入其長壽檢測項目","url":"https://stock-news.laohu8.com/highlight/detail?id=1156640095","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156640095?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 20:32","pubTimestamp":1774355571,"startTime":"0","endTime":"0","summary":"20/20 Biolabs宣布与美国Rokit Healthcare签署独家授权协议，计划将先进的慢性肾病预测技术整合到其长寿检测项目中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}